Asia Deal Watch: ReVance Licenses Chinese Rights To Botox Competitor To Fosun

 
• By Joseph Haas, Ian Haydock, Anju Ghangurde, and Jung Won Shin
  
DealWatch_1200x675

More from Deals

More from Business